FDA Investigator Minerva Rogers

Minerva Rogers has conducted inspections on 145 sites in 14 countries as of 26 Sep 2014. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
145
Last Inspection Date:
26 Sep 2014
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Puerto Rico, Latvia, Taiwan, Costa Rica, United Kingdom of Great Britain and Northern Ireland, Italy, Virgin Islands (U.S.), Dominican Republic, Germany, Sweden, India, Barbados, Malaysia
FDA Investigators that have inspected at least one site in common with Minerva Rogers:
Adaliz Santaliz Cruz, Adree N Anderson, Adrienne Morgan, Agnes M Santori, Akbar J Zaidi, Alan E Mehl, Alicia M Frees, Allison E Sincek, Althea A Williams, Alysia C Alger, Amir A Abdalla, Amy E Devine, Ana Delp Cintron, Ana P Barido, Ana Paulap Sandee, Andrew A Hoopes, Andrew Saunders, Anthony J Ladner, Anthony R Bucks, Aqualia L Nelson, Aref Mel Demerdash, Ashlee M Ward, Ashley A Mutawakkil, Ashley Gonzalez, Avery J Dennis, Barbara I Rogolsky, Barbara Janine Breithaupt, Bonnie E Pierson, Brandi E Williams, Brenda C Hamilton, Brent M Dehaan, Brent T Hall, Brett R Havranek, Brian R Cronenwett, Brittany D Terhar, Bruce E Taylor, Bryan J Love, Carl A Huffman, III, Carl J Montgomery, Carlos Arivera Ramirez, Carmen Y Fisher, Carolyn E Barney, Catherine R Olguin, CDR Sean T Creighton, Chad W Rice, Charles M Spyr, Cheryl D Mccall, Chilton L Ng, Christopher C Wilcox, Christopher D Snyder, Christos G Tsingelis, Clotia Cabbey Mensah, Cody D Rickman, Cody J Alley, Courtney R Tiegs, Cynthia A Harris, MD, RN, Cynthia L Evitt, Cynthia M Goudeau, Dana D Carter, SR DDS, Danial S Hutchison, Daniel R Hurt, Darrah, Darrell E Luedtke, Darrin W Freeman, David A Foran, David F Graham, David J Eide, David L Miser, Dayna I Martinez, Delkis J Caycedo, Diana K Krepel, Diana M Guidry, Dianiris C Ayala, Dina K West, Dolores Harper, Don A Leeseberg, Dwight D Ferguson, Edwin Martinez, Emmanuel A Dimaano, Jr, Eric C Fox, Eric C Nielsen, Eric M Mueller, PharmD, Erickson, Erin C Dugan, Esther A Ofori, Ethan P Stegman, Eva I Merced Medina, Farhana Khan, Frances L Dejesus, Frank S Sedzielarz, Geoffrey K Wong, Gerald T O'connor, Gina Eng, Gregson A Joseph, Gwyn G Dickinson, Heath W Cartwright, Hector Jcolon Torres, Hiwot A Kesi, Huy T Mai, Ingrid Y Johnson, J Michael Cannon, PhD, Jaclyn N Munsch, Jacob G Lutz, Jacqueline M Bowling, Jaime E Pares, James D Planchon, James J Houlihan, James K Ireland, James K Rice, James M Odonnell, James P Mcreavey, James R Montero, Jane E Nelson, Janesa A Licorish, Janete A Eaker, Janete A Oliveira, Jeanne F Broderick, Jeannie M Vonderbrink, Jeffrey A Sincek, Jeffrey B Moody, Jesse A Vazquez, Jessica E Hensley, Jessica L Peterson, Jimmie L Weigand, Joan A Loreng, John A Marchin, Jonathan G Gayechuway, Jonathan R Campos, Jorge E Martinez, Jorge L Guadalupe, Jorge L Lajara, Jorge Martinez, Jose F Pedro, Jose R Lopez, Jose Velez, Joseph R Lambert, Joshua J Silvestri, Julie N Vosilus, Kara L Roden, Karen R Smallwood, Karl D Hezel, Katherine M Taylor, Kathleen J Close, Kellia N Hicks, Kelly D Sheppard, Kelvin Cheung, Kenneth D Bland, Kevin A Beavers, Kinh Q Mac, Kristi B Panzer, Kristi M Hampton Thurston, Laiza V Garcia, Laura E Garcia, Laura S Huffman, LCDR Audra J Lenhart, LCDR Ismael Olvera, IV, LCDR Matthew J Morrison, LCDR Matthew R Mcnew, MPH, REHS/RS, Leonard H Lavi, Leonard Pesetsky, Lewis K Antwi, Libia M Lugo, Linda K Cline, Linda K Matheny, Lindsay P Williams, Linhart, Lionell L Thomas, Lisa D Ellis, Lisa L Flores, Lisa L Gilliam, Lisa M Lopez, Lloyd M Luapula, Lori A Gioia, Louis S Chen, Lourdes Andujar, LT Luis O Rodriguez, LT Prince D Brown, LT Rafael Gonzalez, Luis A Carrion, Marc Balzarini, Margaret A Foster, Margaret A Smithers, Maricelys Mercado, Marilyn Santiago, Marion D Wimberly, Jr, Mark E Chan, Mark R Glover, Mark S Ross, Mary F Bodick, Mary K Concannon, Matthew A Walburger, Matthew P Barnard, Matthew R Sleeter, Maureen A Wentzel, Megan M Kirk, Melinda L Rice, Melissa N Simanton, Michael A Feingold, Michael C Ireland, Michael E Cimaglio, Michele L Obert, Michele Perry Williams, Michelle C Webb, Michelle S Dunaway, Miguel A Martinez Perez, Miguel Gmanzano Maldonado, Milva E Melendez Perales, Minh D Phan, Monica Cburgos Garcia, Monica E Murie, Monique M Brooks, Myra K Casey, Nadine Nanko Johnson, Nancy G Schmidt, Naseem S Jouhari, Neal L Adams, Neisa M Alonso, Nia K Walker, Nicole J Conklin, Noreen Muñiz, Nydia E Colon, Pablo Feliciano, Paige E Shelborne, Paige E Wilson, Patricia L Payne, Patrick L Wisor, Paul A Licata, Paul H Dakin, Peter E Gruman, Peter R Lenahan, Rachel Collen, Rachel T Evans, Rafael E Cruz, Rafael Nevarez Nieves, Ralph H Vocque, Rashonda N Rucker, Raymond T Anderson, Raymond Valdivia, Rebecca Parrilla, Rebecca Rodriguez, Reginald Walker, Richard D Coleman, Richard K Vogel, Rita K Kabaso, Robert E Davis, Robert G Ruff, Robert J Ham, Robert J Nesselhauf, Robert R Wilson, Robert S Woodruff, Robin K Hatfield, Robin K Reel, Rodney D Combs, Roy Baby, Rterry Bolen, Ryan S Martin, Sandra A Boyd, Sandra A Hughes, Sarah L Clark, Scot M Stodola, Scotty L Hargrave, Shafiq S Ahadi, Shanna R Haden, Sharon Giamberini, Shaun M Stracener, Sheri L Stephenson, Shirley J Berryman, Stephanie Mangigian, MS/OSH, RN, Stephen D Eich, Stephen R Souza, Steven C Clifford, Steven P Allen, Sumit Sen, Susan M Miller, Susan M Turcovski, Susanna E Ford, Tamara J Umscheid, Tania E Vizcaino, Tara L Greene, Tara L King, Tara M Aikens, Telicia R White, Tenzin Jangchup, Teresa Jimenez, Teresa M Hillebrandt, Terri L Jones, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Toni S Sturgis, Torrey M Ward, Tristian E Strait, Vaishali J Patel, Veronica Fuentes, MS, Vickie J Kanion, Victor S Pacheco, Victor Spanioli, Victoria A Wagoner, Walsworth, Wanda J Torres, Warren J Lopicka, Wayne D Mcgrath, Weston K Szymanski, William F Lagud, Jr, Yazmith Guzman, Zachary A Bogorad, Zuleika A Pineiro Vargas

Minerva Rogers's Documents

Publish Date Document Type Title
November, 2002 FDA 483 GSK Consumer Health, Inc. - Form 483, 2002-11-15
August, 2000 EIR ZOETIS - EIR, 2000-08-21
January, 2000 EIR Bimeda, Inc. - EIR, 2000-01-25
July, 2002 FDA 483 Perrigo Florida Inc - Form 483, 2002-07-08
December, 2000 FDA 483 Community Blood Center Of Gtr Kansas City, An Operating Division of New York Blood Center, Inc. - Form 483, 2000-12-01
March, 2005 FDA 483 Pall Life Sciences Puerto Rico LLC - Form 483, 2005-03-10
February, 2001 FDA 483 Sparhawk Laboratories, Inc. - Form 483, 2001-02-06
August, 2014 EIR Covidien Surgical Devices - EIR, 2014-08-22
May, 2001 EIR Remel, Inc - EIR, 2001-05-30
March, 2005 EIR Pall Life Sciences Puerto Rico LLC - EIR, 2005-03-10
May, 2001 FDA 483 Remel, Inc - Form 483, 2001-05-30
December, 2000 EIR Community Blood Center Of Gtr Kansas City, An Operating Division of New York Blood Center, Inc. - EIR, 2000-12-01
February, 2001 EIR Sparhawk Laboratories, Inc. - EIR, 2001-02-06
January, 2000 FDA 483 Response Bimeda, Inc. - Form 483R, 2000-08-07
January, 2005 EIR Boston Scientific Corporation - EIR, 2005-01-19
January, 2004 FDA 483 Bayer Healthcare Animal Health Inc - Form 483, 2004-01-26
April, 2000 EIR The Hormone Shop - EIR, 2000-04-28
December, 2003 EIR Exel, Inc. - EIR, 2003-12-30
January, 2004 EIR Bayer Healthcare Animal Health Inc - EIR, 2004-01-26
November, 2002 EIR GSK Consumer Health, Inc. - EIR, 2002-11-15
August, 2000 FDA 483 ZOETIS - Form 483, 2000-08-21
January, 2000 FDA 483 Bimeda, Inc. - Form 483, 2000-01-25
August, 2001 FDA 483 Nostrum Laboratories, Inc. - Form 483, 2001-08-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more